Literature DB >> 23127731

Clostridium difficile infection in patients with chronic kidney disease.

Mira T Keddis1, Sahil Khanna, Amit Noheria, Larry M Baddour, Darrell S Pardi, Qi Qian.   

Abstract

OBJECTIVE: To examine the rate of Clostridium difficile infection (CDI) and hospital-associated outcomes in a national cohort of hospitalized patients with chronic kidney disease (CKD) and assess the impact of long-term dialysis on outcome in these patients. PATIENTS AND METHODS: Data for January 1, 2005, through December 31, 2009 were obtained from the National Hospital Discharge Survey, which includes information on patient demographics, diagnoses, procedures, and discharge types. Data collected and analyzed for this study included age, sex, race, admission type (urgent or emergent combined vs elective), any colectomy diagnosis, length of stay, type of discharge, and mortality. International Classification of Diseases, Ninth Revision, Clinical Modification codes were utilized to identify CKD patients and CDI events. Weighted analysis was performed using JMP version 9.
RESULTS: An estimated 162 million adults were hospitalized during 2005-2009, and 8.03 million (5%) had CKD (median age, 71 years). The CDI rate in CKD patients was 1.49% (0.119 million) compared with 0.70% (1.14 million) in patients without CKD (P<.001). Patients with CKD who were undergoing long-term dialysis were more than 2 times as likely to develop CDI than non-CKD patients and 1.33 times more likely than CKD patients not undergoing dialysis (all P<.001). In a weighted multivariate analysis adjusting for sex and comorbidities, patients with CKD and CDI had longer hospitalization, higher colectomy rate (adjusted odds ratio [aOR], 2.30; 95% confidence interval [CI], 2.14-2.47), dismissal to a health care facility (aOR, 2.22; 95% CI, 2.19-2.25), and increased in-hospital mortality (aOR, 1.55; 95% CI, 1.52-1.59; all P<.001) as compared with CKD patients without CDI. Patients with CKD who were undergoing long-term dialysis did not have worse outcomes as compared with CKD patients who were not undergoing long-term dialysis.
CONCLUSION: These data suggest that patients with CKD have a higher risk of CDI and increased hospital-associated morbidity and mortality. Future prospective studies are needed to confirm these findings and to identify effective CDI prevention in CKD patients, who appear to have an increased risk of CDI acquisition.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23127731      PMCID: PMC3541867          DOI: 10.1016/j.mayocp.2012.05.025

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  29 in total

1.  Recurrent Clostridium difficile infection: an immunodeficiency state?

Authors:  Darrell S Pardi
Journal:  Clin Gastroenterol Hepatol       Date:  2007-06       Impact factor: 11.382

2.  Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes.

Authors:  Elizabeth F O Kern; Miriam Maney; Donald R Miller; Chin-Lin Tseng; Anjali Tiwari; Mangala Rajan; David Aron; Leonard Pogach
Journal:  Health Serv Res       Date:  2006-04       Impact factor: 3.402

3.  Clostridium difficile colitis associated with chronic renal failure.

Authors:  R J Cunney; C Magee; E McNamara; E G Smyth; J Walshe
Journal:  Nephrol Dial Transplant       Date:  1998-11       Impact factor: 5.992

Review 4.  The prognostic importance of a small acute decrement in kidney function in hospitalized patients: a systematic review and meta-analysis.

Authors:  Steven G Coca; Aldo J Peixoto; Amit X Garg; Harlan M Krumholz; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2007-11       Impact factor: 8.860

Review 5.  Clostridium difficile infection associated with antineoplastic chemotherapy: a review.

Authors:  A Anand; A E Glatt
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

6.  Nonrecovery of kidney function and death after acute on chronic renal failure.

Authors:  Chi-yuan Hsu; Glenn M Chertow; Charles E McCulloch; Dongjie Fan; Juan D Ordoñez; Alan S Go
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

Review 7.  Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis.

Authors:  Steven G Coca; Bushra Yusuf; Michael G Shlipak; Amit X Garg; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2009-04-05       Impact factor: 8.860

8.  ICD-9 codes and surveillance for Clostridium difficile-associated disease.

Authors:  Erik R Dubberke; Kimberly A Reske; L Clifford McDonald; Victoria J Fraser
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

9.  Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003.

Authors:  L Clifford McDonald; Maria Owings; Daniel B Jernigan
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

10.  Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

Authors:  Matthew D Redelings; Frank Sorvillo; Laurene Mascola
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

View more
  29 in total

Review 1.  Probiotics and chronic kidney disease.

Authors:  Laetitia Koppe; Denise Mafra; Denis Fouque
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

2.  Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection.

Authors:  Sahil Khanna; Arjun Gupta; Larry M Baddour; Darrell S Pardi
Journal:  Intern Emerg Med       Date:  2015-12-22       Impact factor: 3.397

3.  Proton Pump Inhibitor-Associated C. difficile Infection in a Peritoneal Dialysis Patient.

Authors:  Susan L Ziolkowski; Michelle H Malabanan; Scott E Liebman
Journal:  Perit Dial Int       Date:  2015 Sep-Oct       Impact factor: 1.756

4.  High Mortality Risk in Chronic Kidney Disease and End Stage Kidney Disease Patients with Clostridium Difficile Infection: A Systematic Review and Meta-analysis.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Parkpoom Phatharacharukul; Pailin Mahaparn; Jackrapong Bruminhent
Journal:  J Nat Sci       Date:  2015-04

5.  Clostridium difficile and Laparoscopic Bariatric Surgery: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program Database.

Authors:  ThucNhi T Dang; Jerry T Dang; Muhammad Moolla; Noah Switzer; Karen Madsen; Daniel W Birch; Shahzeer Karmali
Journal:  Obes Surg       Date:  2019-06       Impact factor: 4.129

Review 6.  Clostridium difficile infection: new insights into management.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

7.  Clostridium difficile: the emerging epidemic.

Authors:  Nasia Safdar
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

Review 8.  Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.

Authors:  Raseen Tariq; Siddharth Singh; Arjun Gupta; Darrell S Pardi; Sahil Khanna
Journal:  JAMA Intern Med       Date:  2017-06-01       Impact factor: 21.873

Review 9.  Clostridium difficile infection: management strategies for a difficult disease.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Therap Adv Gastroenterol       Date:  2014-03       Impact factor: 4.409

10.  Outbreak of Clostridium difficile Infections at an Outpatient Hemodialysis Facility-Michigan, 2012-2013.

Authors:  Isaac See; Suparna Bagchi; Stephanie Booth; Daniel Scholz; Andrew I Geller; Lydia Anderson; Heather Moulton-Meissner; Jennie L Finks; Karen Kelley; Carolyn V Gould; Priti R Patel
Journal:  Infect Control Hosp Epidemiol       Date:  2015-04-27       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.